Abstract
OBJECTIVES: The impact of occupational exposures on lung function impairments and quality of life (QoL) in patients with chronic obstructive pulmonary disease (COPD) was analysed and compared with that of smoking.
METHODS: Data from 1283 men and 759 women (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades 1-4 or former grade 0, without alpha-1-antitrypsin deficiency) of the COPD and Systemic Consequences Comorbidities Network cohort were analysed. Cumulative exposure to gases/fumes, biological dust, mineral dust or the combination vapours/gases/dusts/fumes was assessed using the ALOHA job exposure matrix. The effect of both occupational and smoking exposure on lung function and disease-specific QoL (St George's Respiratory Questionnaire) was analysed using linear regression analysis adjusting for age, body mass index, diabetes, hypertension and coronary artery disease, stratified by sex.
RESULTS: In men, exposure to gases/fumes showed the strongest effects among occupational exposures, being significantly associated with all lung function parameters and QoL; the effects were partially stronger than of smoking. Smoking had a larger effect than occupational exposure on lung diffusing capacity (transfer factor for carbon monoxide) but not on air trapping (residual volume/total lung capacity). In women, occupational exposures were not significantly associated with QoL or lung function, while the relationships between lung function parameters and smoking were comparable to men.
CONCLUSIONS: In patients with COPD, cumulative occupational exposure, particularly to gases/fumes, showed effects on airway obstruction, air trapping, gas uptake capacity and disease-related QoL, some of which were larger than those of smoking. These findings suggest that lung air trapping and QoL should be considered as outcomes of occupational exposure to gases and fumes in patients with COPD.
TRIAL REGISTRATION NUMBER: NCT01245933.
Original language | English |
---|---|
Pages (from-to) | 26-33 |
Number of pages | 8 |
Journal | Occupational and Environmental Medicine |
Volume | 81 |
Issue number | 1 |
Early online date | 30 Dec 2023 |
DOIs | |
Publication status | Published - 13 Jan 2024 |
Bibliographical note
Publisher Copyright:© 2023 BMJ Publishing Group. All rights reserved.
Funding
COSYCONET is supported by the German Center for Lung Research (Deutsches Zentrum für Lungenforschung (DZL); grant number 82DZLI05A2 (COSYCONET)), the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung (BMBF), grant number 01GI0881) and is furthermore supported by unrestricted grants from AstraZeneca, Boehringer Ingelheim Pharma, GlaxoSmithKline, Grifols Deutschland and Novartis Deutschland.
Funders | Funder number |
---|---|
Novartis Pharma | |
Bundesministerium für Bildung und Forschung | 01GI0881 |
Deutsches Zentrum für Lungenforschung | 82DZLI05A2 |
Keywords
- Dust
- Epidemiology
- Lung Diseases, Interstitial
- Nicotine
- Occupational Health